• Products
  • MEMO Care

MEMO Care

A New Standard
for ECG Monitoring

Monitoring period can extend to 14 days

Compared to Holter monitoring, which works for up to 48 hours, the MEMO solution enables precise and continuous observation for a maximum of 14 days. The longer the monitoring is activated, the closer the probability of detecting an arrhythmia reaches near 100%, which is demonstrated in clinical trials. With the MEMO solution

it takes only one examination to detect an arrhythmia.

  • Date: August 2021–July 2022
  • Location: Korea University Anam Hospital, Seoul National University Bundang Hospital
  • Subject: 150 patients with suspected cardiac arrhythmia
  • Clinical method: Comparison of the arrhythmia diagnosis rates between 24 hours of Holter monitoring and 14 days of MEMO Patch observation
  • Criteria: * Diagnosis rate of major arrhythmia
  • * Atrial tachycardia, atrial flutter, atrial fibrillation, PSVT, ventricular tachycardia, 2nd or 3rd AV block, sinus pause, and others (e.g., sick sinus syndrome, tachycardia-bradycardia syndrome, R/O WPW syndrome)

100%

Days of monitoring

Arrhythmia diagnosis rate enhanced by AI-based analysis

  • The accuracy rate of diagnosing major arrhythmia increased by 89%

    • Date: August 2021–July 2022
    • Location: Korea University Anam Hospital, Seoul National University Bundang Hospital
    • Subject: 150 patients with suspected arrhythmia
    • Clinical method: Comparison of the arrhythmia diagnosis rates between 24 hours of Holter monitoring and 14 days of MEMO Patch observation
    • Criteria: * Diagnosis rate of major arrhythmia
    • * Atrial tachycardia, atrial flutter, atrial fibrillation, PSVT, ventricular tachycardia, 2nd or 3rd AV block, sinus pause, and others (e.g., sick sinus syndrome, tachycardia-bradycardia syndrome, R/O WPW syndrome)
  • 89%

    Based on number of diagnoses
  • 56.3%

    Based on number of patients

Convenience as testified by patients

  • Date: March1–August 2021
  • Location: Seoul National University Bundang Hospital
  • Target: 58 patients with suspected arrhythmia
  • Clinical method: Comparison of the arrhythmia diagnosis rate between 24 hours of Holter monitoring and 7 days of MEMO Patch observation
  • Criteria: * Diagnosis rate of major arrhythmia
  • * SVT, atrial fibrillation, atrial flutter, sinus pause, 2nd or 3rd AV block, ventricular tachycardia, and ventricular fibrillation

94.8% of surveyed respondents said the device was convenient to wear.


3 easy steps for patients and providers

  • Patient

    1. STEP 01

      Get the MEMO Patch, put on, and go home

    2. STEP 02

      Hand the MEMO Patch in to the hospital after the monitoring period ends

    3. STEP 03

      Visit the hospital and check the results

  • Medical Staff

    1. STEP 01

      Prescribe the MEMO Patch to the patient

    2. STEP 02

      See the updated data

    3. STEP 03

      Review the detailed ECG analysis report and use it for diagnosis


Learn details about the wearable ECG monitoring device, MEMO Patch

The hassle-free MEMO Patch stays attached to the body while that patient goes about daily life.


Track symptoms and sleeping duration via KakaoTalk chatbot and in written notes

Having consistent records of symptoms and sleeping duration are essential for achieving an accurate diagnosis. This tracked data is automatically made available through KakaoTalk chatbot and reflected in the analysis report.* Providers will reference the written notes when diagnosing the patient.


All-in-one care system for patients, MEMO Care

A comprehensive management system for everything from patient care to report creation


Media Kit


Try the MEMO solution now

Request a demo.

[contact-form-7 404 "Not Found"]

Consent to the Collection and Use of Personal Information

Purpose of collection and use For responding to collected requests
Items collected and used Name, Organization (Name of hospital or organization), Phone number, Email, Request details
Retention and use period 3 years from the date of agreement to the collection and use

* You have the right to refuse to consent to the collection and use of personal data. Please note, however, that there may be disadvantages in subscribing if you do not consent.